Search clinical trials for: Macular Pucker

Total 2758 results

Asociación para Evitar la Ceguera en México

Terminated

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

Diffuse Diabetic Macular Edema

Mexico
National Eye Institute (NEI)

Active, not recruiting

Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

AMD

United States
Novartis Pharmaceuticals

Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study (TALON Ext)

Neovascular Age-related Macular Degeneration

United States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Age Related Macular Degeneration

Mexico
National Eye Institute (NEI)

Completed

The Focal Electro-Oculogram in Macular Disease

Age-Related Macular Degeneration | Macular Degeneration

United States
Kubota Vision Inc.
Food and Drug Administration (FDA)

Completed

Safety and Efficacy of Emixustat in Stargardt Disease (SeaSTAR)

Stargardt Disease

United States, United Kingdom, Germany, Spain, Brazil, Canada, Denmark, France, Italy, Netherlands, South Africa
Asociación para Evitar la Ceguera en México

Terminated

Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation (NEPAF)

Macular Edema | Macular Thickening

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters (PFC)

Neovascular
Asociación para Evitar la Ceguera en México

Terminated

Changes in Macular Thickness After Patterns Scan Laser

Proliferative Diabetic Retinopathy | Non Proliferative Diabetic Retinopathy

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Macular Edema

Mexico
Federico II University

Completed

The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome (OCTA and PMCE)

Macular Edema | Cataract

Italy
Asociación para Evitar la Ceguera en México

Terminated

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Epiretinal Membrane | Macular Hole

Mexico
Asociación para Evitar la Ceguera en México
Centro Medico Issemym

Withdrawn

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Subfoveal Choroidal Neovascularization

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Diffuse Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Avastin for Post-photocoagulation Macular Edema

Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
National Eye Institute (NEI)

Active, not recruiting

Natural History of Eye Diseases Related to ABCA4 Mutations

Retinal Degeneration | ABCA4-Related Retinopathies

United States
Hyewon Chung
Bayer

Completed

Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT) (FORESIGHT)

Diabetic Macular Edema

Korea, Republic of
Alvotech Swiss AG

Active, not recruiting

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (ALVOEYE)

Neovascular (Wet) AMD

Slovakia, Czechia, Georgia, Japan, Latvia
Neurotech Pharmaceuticals
The Lowy Medical Research Institute Limited

Completed

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Macular Telangiectasia Type 2

United States, Australia
Kodiak Sciences Inc

Completed

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) (DAYLIGHT)

Wet Age-related Macular Degeneration

United States, Puerto Rico
Paul S. Bernstein

Active, not recruiting

The Moran AMD Genetic Testing Assessment Study (MAGENTA)

Age-Related Macular Degeneration | Genetic Testing | Nutritional Biomarkers

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration

China
Boehringer Ingelheim

Completed

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia (HORNBILL)

Diabetic Retinopathy

United States, United Kingdom
Federico II University

Completed

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC (OCTA)

Macular Degeneration Choroidal Neovascularization

Italy
Meddoc
Oslo University Hospital

Completed

Validation of Bulbicam for DR- and AMD-patients

Age-Related Macular Degeneration | Diabetic Retinopathy

Norway
Bayer
Regeneron Pharmaceuticals

Active, not recruiting

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye (PULSAR)

Neovascular Age-Related Macular Degeneration

Spain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
NYU Langone Health
National Eye Institute (NEI)

Completed

Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations

Glaucoma | Eye Diseases | Age-Related Macular Degeneration | Diabetic Retinopathy | Central Serous Chorioretinopathy | Glaucoma, Suspect

United States
Novartis Pharmaceuticals

Active, not recruiting

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema (BLUE SKY)

Diabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (nAMD)

Germany
Novartis Pharmaceuticals

Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) (TALON)

Age-related Macular Degeneration

United States, Austria, Czechia, Italy, Taiwan, Belgium, Germany, Australia, Israel, Canada, France, Spain, Korea, Republic of, United Kingdom, Portugal, Netherlands, Sweden, Argentina, Malaysia, Switzerland
Bio-Thera Solutions

Active, not recruiting

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

Neovascular (Wet) Age-related Macular Degeneration

China
Unity Biotechnology, Inc.

Completed

Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)

Diabetic Macular Edema (DME)

United States, Canada
University of Athens

Completed

Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion (INTRAMED-CRVO)

Retinal Vein Occlusion | Vascular Occlusive Disease
Columbia University
National Eye Institute (NEI)

Completed

Macular Damage in Early Glaucoma and Progression

Glaucoma

United States
Astellas Pharma Global Development, Inc.

Active, not recruiting

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Stargardt's Macular Dystrophy

Italy, United States, Israel, United Kingdom, Germany, Spain, Hungary, France
Ionis Pharmaceuticals, Inc.

Active, not recruiting

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Macular Degeneration | Geographic Atrophy

United States, Spain, Australia, Austria, Canada, Czechia, Netherlands, New Zealand, Poland
URAL Telekomunikasyon San. Trade Inc.

Completed

Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images

Glaucoma | Eye Diseases | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Retinal Vein Occlusion

Turkey
Hoffmann-La Roche

Active, not recruiting

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Diabetic Macular Edema

United States, United Kingdom, Korea, Republic of, Argentina, Poland, Puerto Rico, Czechia, Spain, Canada
Novartis Pharmaceuticals

Active, not recruiting

Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

Diabetic Macular Edema

Japan
University of Colorado, Denver
National Institute on Aging (NIA)

Completed

Advancing Understanding of Transportation Options (AUTO)

Stroke | Multiple Sclerosis | Glaucoma | Brain Injuries | Macular Degeneration | Arthritis | Chronic Obstructive Pulmonary Disease | Parkinson Disease | Restless Legs Syndrome | Diabetic Retinopathy | Insomnia | Retinitis Pigmentosa | Obstructive Sleep Apnea | Dementia | End Stage Renal Disease | Sleep Apnea | Syncope | Seizures and other conditions

United States
Regeneron Pharmaceuticals

Active, not recruiting

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Diabetic Macular Edema (DME) | Neovascular Age-Related Macular Degeneration (nAMD)

United States
The University of Hong Kong

Completed

Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Age-Related Macular Degeneration

Hong Kong
Moorfields Eye Hospital NHS Foundation Trust
Bayer

Completed

Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study (AMOUR)

Retinitis Pigmentosa | Macular Oedema

United Kingdom
AsclepiX Therapeutics, Inc.

Active, not recruiting

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) (DISCOVER)

Neovascular Age-related Macular Degeneration

United States
Novartis Pharmaceuticals

Active, not recruiting

Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal (BLUESKY-PT)

Neovascular Age-related Macular Degeneration (nAMD)

Portugal
Curacle Co., Ltd.
Théa Open Innovation, France

Completed

The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States, Puerto Rico
Baylor College of Medicine
United States Department of Agriculture (USDA)

Active, not recruiting

Maternal Carotenoids Across Pregnancy Study (MCAPS)

Pregnancy Related | Healthy Nutrition

United States
Astellas Pharma Global Development, Inc.

Active, not recruiting

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Age-Related Macular Degeneration | Geographic Atrophy

United States, Italy, Latvia, France, Israel, Germany, Spain, Hungary, Brazil, Canada, Argentina, Colombia, Croatia, Australia, Austria, Belgium, Czechia
Bayer

Completed

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema (VISION-AF)

Diabetic Macular Edema

India

Search clinical trials for: Macular Pucker

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations